[1]
2026. Review of Next-Generation Non-Dopaminergic Antipsychotic Agents Targeting Central Muscarinic Receptors: Review Article. Journal of Pharma Insights and Research. 4, 4 (Aug. 2026), 201–216. DOI:https://doi.org/10.69613/fep10t11.